Atomized Content
download
Purpose
The BSI-18 allows for Assessment of psychological distress and psychiatric disorders in the general population.
Link to Instrument
Area of Assessment
Mental FunctionsActivities & Participation
We're hiring! Browse jobs and apply today.
The BSI-18 allows for Assessment of psychological distress and psychiatric disorders in the general population.
18
4 minutes
Adolescents
13 - 17
yearsAdults
18 - 64
yearsOlder Adults
+
yearsMelanie Mortham, Caroline Schanche, Sarah Peters, Matt Wilson, Dan Fleming
Cancer survivors: (Recklitis, 2017; n = 250; Mean age = 29.45 (9.77)
Cancer survivors: (Zabora, 2001; n=1543; Mean age 55.5 +/- 14.5 (range= 14-90 years)
Cancer survivors: (Recklitis, 2017; n = 250; Mean age = 29.45 (9.77)
BSI-18 Global Severity Index t-scores GSI t-score < 50 163 65.2 GSI t-score 50 – 56 43 17.2 GSI t-score 57 – 62 20 8.0 GSI t-score ≥ 63 24 9.6
Breast cancer survivors: (Galdón, 2008; n = 175; Mean age= 52.7 (10.12)
Mean (S.D.) and item–total scale correlation for items in three BSI-18 dimensions (N=175)
Mean (S.D.) Item–total scale correlation Factor I: somatization dimension 4.62 (4.26) 1. Faintness or dizziness 0.50 (1.03) .42 4. Pain on heart or chest 0.91 (1.24) .38 7. Nausea or upset stomach 0.90 (1.33) .42 10. Trouble getting one's breath 0.50 (1.06) .25 13. Numbness or tingling in parts of one's body 1.01 (1.29) .30 16. Feeling weak in parts of one's body 0.77 (1.25) .37 Factor II: depression dimension 4.68 (4.60) 2. Feeling no interest in things 0.80 (1.36) .38 5. Feeling lonely 0.71 (1.34) .51 8. Feeling blue 2.04 (1.44) .53 11. Feeling worthless 0.17 (0.66) .63 14. Feeling hopeless about the future 0.85 (1.33) .55 17. Thoughts of ending one's life 0.13 (0.58) .26 Factor III: anxiety dimension 7.27 (5.10) 3. Nervousness or shakiness inside (GA) 2.62 (1.31) .63 6. Feeling tense or keyed up (GA) 1.85 (1.60) .69 15. Feeling so restless that one could not sit still (GA) 0.86 (1.41) .37 9. Suddenly scared for no reason (P) 0.85 (1.36) .37 12. Spells of terror or panic (P) 0.10 (0.48) .26 18. Feeling fearful (P) 1.01 (1.47) .42 General distress 16.64 (10.96)P=item with saturation in the panic factor in the empirical model; GA=item with saturation in the general anxiety factor in the empirical model.
Cancer survivors: (Zabora, 2001; n=1543; Mean age 55.5 +/- 14.5 (range= 14-90 years)
Breast cancer survivors: (Galdón, 2008; n = 175; Mean age= 52.7 (10.12)
Parkinson ’s disease: (Carrozzino, 2019; n = 472; Mean age = 65.2 (10.3)) years, 60% male)
Mean (sd) for the individual subscales and the corresponding effect size.
BSI-18 subscales Italian PD-patients N = 472 Italian general population N = 333 Effect size Depression-6 0.95 (0.79) 0.50 (0.57) 0.64 Anxiety-6 0.95 (0.73) 0.49 (0.54) 0.70 Somatization-6 0.99 (0.64) 0.41 (0.52) 0.98 GSI-18 0.97 (0.61) 0.47 (0.46) 0.90 SCL-90-R subscales Phobic anxiety-7 0.63 (0.64) 0.14 (0.29) 0.93 Somatization-12 1.16 (0.64) 0.54 (0.52) 1.04 Psychoticism-10 0.60 (0.52) 0.26 (0.35) 0.74Abbreviations throughout the table. BSI-18 = Brief Symptom Inventory. GSI-18 = Global Severity Index.
Parkinson ’s disease: (Abraham, 2017; n = 1067; Mean age = 65.3 (10.85), 61.8% male)
Transformation to normalized T-scores including cut off for ≥63 as well as ≥65 to indicate percentage of symptoms of psychological distress in PD patients (N = 472). Prevalence in percent.
BSI-18 subscales
Study by Abraham et al. (2017) N = 1067
T-scores
Prevalence %
≥63
Depression-6
50.8
15.4%
Anxiety-6
52.1
15.0%
Somatization-6
54.6
22.5%
GSI-18
53.4
18.7%
Parkinson ’s disease: (Carrozzino, 2019; n = 472; Mean age = 65.2 (10.3)) years, 60% male)
Transformation to normalized T-scores including cut off for ≥63 as well as ≥65 to indicate percentage of symptoms of psychological distress in PD patients (N = 472). Prevalence in percent.
BSI-18 subscales
Present study PD patients = 472
T-scores
Prevalence %
≥63
≥65
Depression-6
56.7
27.5%
22.0%
Anxiety-6
57.3
29.6%
23.3%
Somatization-6
61.8
47.7%
38.8%
GSI-18
59.5
36.4%
28.4%
SCL-90-R subscales
Phobic anxiety-7
64.4
55.5%
55.5%
Somatization-12
61.6
45.1%
36.2%
Psychoticism-10
59.5
36.9%
29.9%
Abbreviations throughout the table. BSI-18 = Brief Symptom Inventory. GSI-18 = Global Severity Index.
NA = Not Available. PD = Parkinson's disease.
Parkinson ’s disease: (Carrozzino, 2019; n = 472; Mean age = 65.2 (10.3)) years, 60% male)
Effect size: (>/+ 0.8 is significant)
Somatization-6: 0.98
Depression-6: 0.64
GSI-18: 0.90
Elderly community-based adults in Germany: (Petrowski, 2018); n=884; Mean Age= 70.75 (7.08); age range =60-95 years
Items
M (SD)
Scale 1: Somatization (ω = .826)
∑2.36 ± 3.07
1 Faintness or dizziness
0.31 ± 0.62
4 Pains in heart or chest
0.41 ± 0.70
7 Nausea or upset stomach
0.34 ± 0.66
10 Trouble getting your breath
0.39 ± 0.72
13 Numbness or tingling in parts of your body
0.34 ± 0.69
16 Feeling weak in parts of your body
0.57 ± 0.82
Scale 2: Depression (ω = .890)
∑2.04 ± 3.34
2 Feeling no interest in things
0.42 ± 0.73
5 Feeling lonely
0.55 ± 0.92
8 Feeling blue
0.34 ± 0.72
11 Feelings of worthlessness
0.27 ± 0.65
14 Feeling hopeless about the future
0.38 ± 0.79
17 Thoughts of ending your life
0.08 ± 0.34
Scale 3: Anxiety (ω = .857)
∑1.55 ± 2.72
3 Nervousness or shakiness inside
0.31 ± 0.62
6 Feeling tense or keyed up
0.45 ± 0.74
9 Suddenly scared for no reason
0.23 ± 0.57
12 Spells of terror or panic
0.13 ± 0.43
15 Feeling so restless you could not sit still
0.23 ± 0.61
18 Feeling fearful
0.21 ± 0.55
Global Severity Index (ω = .929)
∑5.96 ± 8.08
Elderly community-based adults in Germany: (Petrowski, 2018); n=884; Mean Age= 70.75 (7.08); age range =60-95 years
Elderly community-based adults in Germany: (Petrowski, 2018); n=884; Mean Age= 70.75 (7.08); age range =60-95 years
Random sample of German Citizens: (Franke, 2017; n = 2516; Mean Age= 50.5 (18.6)
Random sample of German Citizens: (Franke, 2017; n = 2516; Mean Age= 50.5 (18.6)
Abraham, Danielle S., et al. “The Factor Structure of the Brief Symptom Inventory-18 (BSI-18) in Parkinson Disease Patients.” Journal of Psychosomatic Research, vol. 96, 2017, pp. 21–26., doi:10.1016/j.jpsychores.2017.03.002.
Carrozzino, Danilo, et al. “The Prevalence of Psychological Distress in Parkinson's Disease Patients: The Brief Symptom Inventory (BSI-18) versus the Hopkins Symptom Checklist (SCL-90-R).” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 88, 2019, pp. 96–101., doi:10.1016/j.pnpbp.2018.07.012.
Franke, Gabriele Helga, et al. "Psychometric analysis of the brief symptom inventory 18 (BSI-18) in a representative German sample." BMC Medical Research Methodology, vol. 17, no. 1, 2017. Academic OneFile, http://link.galegroup.com/apps/doc/A479093671/AONE?u=duke_perki ns&sid=AONE&xid=6f31f29b. Accessed 23 May 2019.
Galdón MJ, Durá E, Andreu Y,Ferrando M,Murgui S, Pérez S, Ibañez E,Psychometric properties of the Brief Symptom Inventory-18 in a Spanish breast cancer sample, Journal of Psychosomatic Research, Volume 65, Issue 6, 2008,Pages 533-539,ISSN 0022-3999, https://doi.org/10.1016/j.jpsychores.2008.05.009. (http://www.sciencedirect.com/science/article/pii/S002239990800226 2)
Hakami RM. Prevalence of psychological distress among undergraduate students at Jazan University: A cross-sectional study. Saudi J Med Med Sci 2018;6:82-8.
Meachen, Sarah-Jane, et al. “The Reliability and Validity of the Brief Symptom Inventory−18 in Persons With Traumatic Brain Injury.” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 5, 2008, pp. 958–965., doi:10.1016/j.apmr.2007.12.028.
Petrowski K, Schmalbach B, Jagla M, Franke GH, Brähler E. Norm values and psychometric properties of the brief symptom inventory-18 regarding individuals between the ages of 60 and 95. BMC Medical Research Methodology. 2018;18. https://login.proxy.lib.duke.edu/login?url=https://search.proquest.co m/docview/2158329978?accountid=10598. doi: http://dx.doi.org/10.1186/s12874-018-0631-6.
Recklitis CJ, Blackmon JE, Chang G. Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview. Psychological Assessment. 2017;29(10):1189-1200. doi:10.1037/pas0000427.supp (Supplemental). https://www.ncbi.nlm.nih.gov/pubmed/28080106
We have reviewed more than 500 instruments for use with a number of diagnoses including stroke, spinal cord injury and traumatic brain injury among several others.